EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type

Lennart Harland, Vanessa Borgmann, Franziska Otto, Mathis Overkamp, Irina Bonzheim, Falko Fend, Leticia Quintanilla-Martinez, Dominik Nann

Modern Pathology · 2024-07 · 37 (7) · 100519

DOI: 10.1016/j.modpat.2024.100519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024-07. Verfasst von Lennart Harland und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology and Neuropathology, University Hospital Tuebingen and Comprehensive Cancer Center, Tuebingen, Germany; Department of Hematolog…. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Bone Marrow, Mutation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Follicular helper T-cell (TFH) lymphoma harbors recurrent mutations of RHOAG17V, IDH2R172, TET2, and DNMT3A. TET2 and DNMT3A mutations are the most frequently affected genes in clonal hematopoiesis (CH). The aim of our study was to investigate the frequency of CH in bone marrow biopsies (BMB) of TFH/angioimmunoblastic T-cell lymphoma (TFH-AITL) patients and its association with myeloid neoplasms. A total of 29 BMB from 22 patients with a diagnosis of TFH-AITL were analyzed by next-generation sequencing (NGS) with a custom panel. Morphologically, 5 BMB revealed that TFH-AITL infiltrates of >5% of bone marrow (BM) cellularity confirmed in 4 cases by NGS-based T-cell clonality. IDH2R172 was demonstrated only in 1 (3%) of 29, and RHOAG17V in 2 (7%) of 29 samples. TET2 and DNMT3A were identified in 24 (83%) of 29 and 17 (59%) of 29 BMB, respectively. In the parallel lymph node the frequencies of mutations were 27% (IDH2R172), 64% (RHOAG17V), 86% (TET2), and 50% (DNMT3A). TET2 and/or DNMT3A mutations identical in lymph node and BMB were present in 18 (82%) of 22 patients, regardless of BM infiltration. In 3 cases the CH mutations were detected 13, 41, and 145 months before TFH-AITL diagnosis. Cases with TET2/DNMT3A mutations and BM variant allele frequencies >40% (7/18, 39%) showed lower blood counts. However, only low platelet count was statistically significant (P = .024). Myeloid neoplasms and/or myelodysplastic syndrome-related mutations were identified in 4 cases (4/22; 18%); all with high TET2 variant allele frequencies (>40%; P = .0114). In conclusion, CH is present in 82% of TFH-AITL and can be demonstrated up to 145 months before TFH-AITL diagnosis. NGS T-cell clonality analysis is an excellent tool to confirm TFH-AITL BM infiltration. Concurrent myeloid neoplasms were identified in 18% of the cases and were associated with TET2 mutations with high allelic burden (>40%). We demonstrated that myeloid neoplasms might occur simultaneously or precede the diagnosis of TFH lymphoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisBone MarrowMutationHumansMaleFemaleMiddle AgedAgedAged, 80 and overAdultImmunoblastic LymphadenopathyLymphoma, FollicularT-Lymphocytes, Helper-InducerHigh-Throughput Nucleotide SequencingDNA Methyltransferase 3ADNA-Binding ProteinsDioxygenases

Stichwörter der Autor:innen

bone marrow biopsyclonal hematopoiesisclonality analysisfollicular helper T-cell lymphomanext-generation sequencing

Substanzen

DNA Methyltransferase 3ATET2 protein, humanDNMT3A protein, humanDNA-Binding ProteinsDioxygenases

Autor:innen und Institutionen

  • Institute of Pathology and Neuropathology, University Hospital Tuebingen and Comprehensive Cancer Center, Tuebingen, Germany; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital…
  • Institute of Pathology and Neuropathology, University Hospital Tuebingen and Comprehensive Cancer Center, Tuebingen, Germany.
  • Institute of Pathology and Neuropathology, University Hospital Tuebingen and Comprehensive Cancer Center, Tuebingen, Germany. Electronic address: leticia.quitanilla-fend@med.uni-tuebingen.de.

Zitieren

APA

Harland, L., Borgmann, V., Otto, F., Overkamp, M., Bonzheim, I., Fend, F., Quintanilla-Martinez, L., & Nann, D. (2024). Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type. Modern Pathology, 37(7), 100519. https://doi.org/10.1016/j.modpat.2024.100519

Vancouver

Harland L, Borgmann V, Otto F, Overkamp M, Bonzheim I, Fend F, et al. Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type. Modern Pathology. 2024;37(7):100519. doi:10.1016/j.modpat.2024.100519

BibTeX
@article{Harland2024,
  author = {Harland, Lennart and Borgmann, Vanessa and Otto, Franziska and Overkamp, Mathis and Bonzheim, Irina and Fend, Falko and Quintanilla-Martinez, Leticia and Nann, Dominik},
  title = {Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type},
  journal = {Modern Pathology},
  year = {2024},
  volume = {37},
  number = {7},
  pages = {100519},
  doi = {10.1016/j.modpat.2024.100519}
}
Kostenlos starten →